1 / 26

PHARMACOLOGY

PHARMACOLOGY. GASTROINTESTINAL DRUGS. Drugs For Peptic Ulcer. 1. Reduction of gastric acid secretion ( a) H2 antihistamines : Cimetidine Ranitidine Famotidine Roxatidine (b) Proton pump inhibitors : Omeprazoie Lansoprazole Pantoprazole Rabeprazole Esomeprazole

jatin
Télécharger la présentation

PHARMACOLOGY

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. PHARMACOLOGY GASTROINTESTINAL DRUGS

  2. Drugs For Peptic Ulcer

  3. 1. Reduction of gastric acid secretion (a) H2 antihistamines : Cimetidine Ranitidine Famotidine Roxatidine (b) Proton pump inhibitors: Omeprazoie Lansoprazole Pantoprazole Rabeprazole Esomeprazole (c) Anticholinergics: Pirenzepine Propantheline Oxyphenonium (d) Prostaglandin analogue Misoprostol

  4. 2. Neutralization of gastric acid (Antactids) Systemic: Sodium bicarbonate Sod.citrate (b) Non Systemic: Magnesium hydroxide gel Mag. Trisilicate Aluminium hydroxide Magaldrate Calcium carbonate 3. Ulcer protectives: Sucralfate Colloidal bismuth subcitrate (CBS)

  5. 4. Anti-H. pylori drugs: Amoxicillin Clarithromycin Metronidazole Tinidazole Tetracycline

  6. H2 antagonists Mechanisms of Action Suppress secretory responses to food stimulation and nocturnal secretion of gastric acid via their ability to decrease (indirectly) the activity of the proton pump. H2 blockers also partially antagonize HCl secretion caused by vagal stimulation or by gastrin. Clinical Uses Acid peptic disease (overall less effective than proton pump inhibitors) gastroesophageal reflux disease(GERD) Zollinger-Ellison syndrome

  7. Adverse Effects GI distress, dizziness, somnolence; slurred speech and delirium possible in elderly. Cimetidine is a major inhibitor of Cyt.P450 isoforms Increase drug interaction via increasing effects of quinidine, phenytoin, tricyclic antidepressants and warfarin. Cimetidine decreases androgens gynecomastia

  8. Proton Pump Inhibitors Mechanisms of Action Omeprazole and related "-prazoles" are irreversible, direct inhibitors of the proton pump(K+/H+ antiporter) in the gastric parietal cell Clinical Uses They are more effective than H2 blockers in peptic ulcer disease (PUD) and are also effective in GERD and Zollinger-Ellison syndrome. Adverse Effects May cause mild CNS and GI effects and decrease bioavailability of drugs that require acidity for oral absorption (e.g., fluoroquinolones, ketoconazole). Inhibit P450 decrease elimination of diazepam, phenytoin and warfarin

  9. ANTICHOLINERGIC Mechanism of Action Anticholinergic drugs reduce the volume of gastric juice without raising its pH unless there is food in stomach to dilute the secreted acid

  10. Prostaglandin Analogue Mechanisms of Action PGE2 analog, which is cytoprotective increases mucus and bicarbonate secretion. Clinical Uses Selective use in NSAID-induced GI ulcers. Major problems in the use of misoprostol are- diarrhoea, abdominal cramps, uterine bleeding, abortion, and need for multiple daily doses.

  11. Antacids Mechanisms of Action Ca, Mg, and Al hydroxides that neutralize protons in the gut lumen Adverse Effects May increase oral absorption of azoles, fluoroquinolones, and tetracyclines

  12. Ulcer protectives Mechanisms of Action Polymerizes on GI luminal surface to form a protective gel-like coating of ulcer beds Clinical Uses Increase healing and decrease ulcer recurrence. Sucralfate requires acid pH, antacids may interfere. Bismuthsubsalicylate is also protective. Adverse effects Sucralfate: constipation hypophosphatemia Dry mouthand nausea are infrequent

  13. CBS: diarrhoea, headache and dizziness. Prolonged use has the potential to cause osteodystrophy and encephalopathy

  14. ANTI HELICOBACTER PYLORI DRUGS Two weeks regimes (mg) 1. Amoxicillin 750 + Tinidazole 500 + Omeprazole 20 all BD 2. Amoxicillin 750 + Tinidazole 500 +Lansoprazole30 all BD 3. Clarithromycin 250 + Tinidazole 500 +Lansoprazole30 all BD 4. Clarithromycin 500 + Amoxicillin 1000 +Lansoprazole30 all BD 5. Clarithromycin 500 BD/Amoxicillin750 BD + Omeprazole 20 BD 6 Amoxicillin 500 TDS/Tetracycline500 QID + Metronidazole 400 QID/Tinidazole500 BD + Bismuth 120 QID 7. Amoxicillin 750 TDS + Metronidazole 500 TDS + Ranitidine 300 OD 8. Amoxicillin 750 BD + Clarithromycin 250 BD + Lansoprazole 30 BD

  15. Emetic Pathways and Drug Actions

  16. CLASSIFICATION OF ANTIEMETICS AnticholinergicsHyoscine, Dicyclomine 2. H1 antihistaminics Promethazine, Diphenhydramine, Dimenhydrinate, Doxylamine, Cyclizine, Meclozine, Cinnarizine 3. Neuroleptics Chlorpromazine, Prochlorperazine, Haloperidol, etc 4. Prokineticdrugs Metoclopramide Domperidone, Cisapride, Mosapride Tegaserod

  17. 5. 5-HT3 antagonists Ondansetron, Granisetron 6. Adjuvant Dexamethasone, antiemetics Benzodiazepines, Cannabinoids

  18. Opioid analgesics (eg, morphine) have duality of action: decrease emesis by activating receptors that decrease pain transmission and increase emesis by activating receptors In the CTZ

  19. ANTICHOLINERGIC Mechanisms of Action: It acts probably by blocking conduction of nerve impulses across cholinergic link in the pathway leading from the vestibular apparatus to the vomiting centre. Use: effective drug for motion sickness. . Adverse effect: brief duration of action Sedation Other anticholinergic actions

  20. H1ANTIHISTAMINICS Mechanisms of Action It actsby inhibiting influx of Ca++ from endolymphinto the vestibular sensory cells which mediates labyrinthine reflex. Uses: -mainly in motion sickness and -to a lesser extent in morning sickness -postoperative vomiting. Adverse effects: drowsiness, dry mouth, vertigo and abdominal upset

  21. Neuroleptics MOA Act by Blocking D2 receptors in the CTZ Antagonize apomorphineinduced vomiting and Have additional antimuscarinicas well as H1 antihistaminic property. Uses Drug induced and postanaestheticnausea and vomiting. (b) Disease induced vomiting: gastroenteritis, uraemia, liver disease, migraine, etc. (c) Malignancy associated and cancer chemotherapy (mildly emetogenic) induced vomiting. (d) Radiation sickness vomiting (less effective). (e) Morning sickness: should not be used except in hyperemesis gravidarum

  22. Adverse effect sedation. Acute muscle dystonia may occurafter a single dose, especially in children and girls. The antiemetic dose is generally much lower than antipsychotic doses. These agents should not be administered until the cause of vomiting has been diagnosed; otherwise specific treatment of conditions like intestinal obstruction, appendicitis maybe delayed due to symptom relief.

  23. PROKINETIC DRUGS These are drugs which promote gastrointestinal transit and speed gastric emptying by enhancing coordinated propulsive motility. METOCHLOPROMIDE MOA: D2 antagonism 5-HT4 agonism 5-HT3 antagonism Uses Antiemetic postoperative, Drug induced, disease associated(especially migraine), radiation sickness is less effective in motion sickness

  24. 2. Gastrokinetic : To accelerate gastric emptying (a) When emergency general anaesthesia isto be given and the patient has taken foodless than 4 hours before. (b) To relieve postvagotomy or diabetesassociated gastric stasis. (c) To facilitate duodenal intubation 3. Dyspepsia and other functional g.idisorders. Metoclopramide may succede in stoppingpersistent hiccups 4. Gastroesophageal reflux disease(GERD) Metoclopramide may afford symptomatic relief in milder cases of GERD

  25. Adverse effects Metoclopramide is generally well tolerated. Sedation, dizziness, loose stools, muscle dystonias(especially in children) are the main side effects. Long-term use can cause parkinsonism, galactorrhoea and gynaecomastia. It should not be used to augment lactation. Though the amount secreted in milk is small, but suckling infant may develop loose motions, dystonia, myoclonus.

  26. 5HT3 ANTAGONISTs MOA It blocks the depolarizing action of 5-HT through 5-HT3 receptors on vagal afferents in the g.i.t as well as NTS and CTZ. Uses: cancer chemotherapy/radiotherapy induced vomiting. Adverse effect the only common side effect is headache Mild constipation or diarrhoea and abdominal discomfort occur in few patients

More Related